BCL2 and colorectal cancer: Consistent with this observation, recent studies suggest that a high rate of stem cell apoptosis in the small intestine is partially responsible for the low incidence of small intestine cancer compared to colorectal cancer; in the latter, the stem cell is protected from undergoing apoptosis by the expression of bcl-2, an anti-apoptosis protein [50] .